3 Factor Indexing’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
3 Factor Indexing's BBIO Position: Q3 2026 in Review
3 Factor Indexing held its BridgeBio Pharma (BBIO) position steady in Q3 2026 at 1 share worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #412.
3 Factor Indexing first reported a position in BBIO in Q1 2026 and has held it in 3 quarters since. The position peaked at $75 in Q2 2026. 470 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- 3 Factor Indexing held 1 share of BridgeBio Pharma worth $66 as of Q3 2026.
- 3 Factor Indexing left its BridgeBio Pharma share count unchanged in Q3 2026.
- BridgeBio Pharma made up ﹤0.01% of 3 Factor Indexing's portfolio in Q3 2026, its #412 holding.
- 3 Factor Indexing first reported a position in BridgeBio Pharma in Q1 2026 and has held it in 3 quarters since.
- 3 Factor Indexing's BridgeBio Pharma position peaked at $75 in Q2 2026.
- 470 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on 3 Factor Indexing's 13F filing for Q3 2026, filed 15 Oct 2026.